These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7520315)

  • 1. HIV-1-O: a variant of HIV-1.
    Commun Dis Rep CDR Wkly; 1994 Jun; 4(24):109. PubMed ID: 7520315
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon.
    Nkengasong JN; Peeters M; vanden Haesevelde M; Musi SS; Willems B; Ndumbe PM; Delaporte E; Perret JL; Piot P; van den Groen G
    AIDS; 1993 Nov; 7(11):1536-8. PubMed ID: 8280429
    [No Abstract]   [Full Text] [Related]  

  • 3. The genetic variability of HIV-1 and its implications.
    Peeters M
    Transfus Clin Biol; 2001 Jun; 8(3):222-5. PubMed ID: 11499964
    [No Abstract]   [Full Text] [Related]  

  • 4. CTL cross reactivity between HIV strains.
    Jolly D; Chada S; Townsend K; DeJesus C; Chang S; Weinhold K; Anderson CG; Lynn A; Bodner M; Barber J
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1369-71. PubMed ID: 1466957
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of HIV-1 group O infection--Los Angeles county, California, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(26):561-5. PubMed ID: 9132574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic assays for HIV-1 infection.
    Truong HM; Klausner JD
    MLO Med Lab Obs; 2004 Jul; 36(7):12-3, 16, 18-20; quiz 22-3. PubMed ID: 15318787
    [No Abstract]   [Full Text] [Related]  

  • 7. Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon.
    Janssens W; Nkengasong JN; Heyndrickx L; Fransen K; Ndumbe PM; Delaporte E; Peeters M; Perret JL; Ndoumou A; Atende C
    AIDS; 1994 Jul; 8(7):1012-3. PubMed ID: 7946088
    [No Abstract]   [Full Text] [Related]  

  • 8. False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.
    McKellar MS; Jongthavorn P; Khanlou H
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):644. PubMed ID: 18362696
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunofluorescence assay in India for confirmation of HIV-1 infection using a T-cell line infected with defective HIV-1.
    Bala M; Arias JF; Deb M; Ikuta K
    Int J Infect Dis; 2010 Dec; 14(12):e1093-8. PubMed ID: 20952236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency viruses. Detection and pathogenesis.
    Levy JA
    Immunol Ser; 1989; 44():159-229. PubMed ID: 2489112
    [No Abstract]   [Full Text] [Related]  

  • 11. Summary of the Antigenic Variation Working Group.
    Bradac J; Ho D
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1419-21. PubMed ID: 1466971
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 group N: travelling beyond Cameroon.
    Delaugerre C; De Oliveira F; Lascoux-Combe C; Plantier JC; Simon F
    Lancet; 2011 Nov; 378(9806):1894. PubMed ID: 22118443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Persistent viruses in serological diagnosis of HIV infection].
    Khaitov RM; Glushchenko MV; Trubcheninova LP; Prokopenko VD
    Vestn Ross Akad Med Nauk; 1992; (9-10):59-62. PubMed ID: 1283724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV receptors and the pathogenesis of AIDS.
    Weiss RA
    Science; 1996 Jun; 272(5270):1885-6. PubMed ID: 8658158
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of a WHO workshop on synthetic peptides in HIV diagnosis and AIDS-related research, Moscow 24-26 May 1989. World Health Organization Global Programme on AIDS.
    AIDS; 1991 Jan; 5(1):WHO1-9. PubMed ID: 1711860
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants.
    Koch WH; Sullivan PS; Roberts C; Francis K; Downing R; Mastro TD; Nkengasong J; Hu D; Masciotra S; Schable C; Lal RB
    J Clin Microbiol; 2001 Mar; 39(3):1017-20. PubMed ID: 11230420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HIV-1 group O infection--1996. From the Centers for Disease Control and Prevention.
    JAMA; 1996 Aug; 276(7):521-2. PubMed ID: 8709390
    [No Abstract]   [Full Text] [Related]  

  • 18. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition.
    Rowland-Jones SL; Phillips RE; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; Bangham CR; Rizza CR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1353-4. PubMed ID: 1466955
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; Sigmund K; Bangham CR
    Nature; 1995 Jun; 375(6532):606-11. PubMed ID: 7791879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.
    Schable C; Zekeng L; Pau CP; Hu D; Kaptue L; Gurtler L; Dondero T; Tsague JM; Schochetman G; Jaffe H
    Lancet; 1994 Nov; 344(8933):1333-4. PubMed ID: 7968029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.